Viewing Study NCT06771934


Ignite Creation Date: 2025-12-25 @ 2:40 AM
Ignite Modification Date: 2025-12-28 @ 10:34 PM
Study NCT ID: NCT06771934
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-01-13
First Post: 2025-01-07
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Combination Therapy of Omalizumab and Allergen Immunotherapy for Moderate to Severe Asthma
Sponsor: Qianfoshan Hospital
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module